Symposium Speakers

The BIBC symposium will be showcasing cutting edge research in brain cancer biology and novel technologies

By bringing together a multi-disciplinary group of researchers, we can advance technological innovations for brain cancer patients.

Keynote Speakers

Steven Kalkanis, MD

CEO of the Henry Ford Medical Group (HFMG) and Senior Vice President and Chief Academic Officer of Henry Ford Health System


Justin Hanes, PhD

Director, Center for Nanomedicine, Lewis J. Ort Professor of Ophthalmology at Johns Hopkins Medicine


Confirmed Speakers

Peter Fecci, MD, PhD, Duke University

Dolores Hambardzumyan, PhD, MBA, Icahn School of Medicine at Mount Sinai

Shawn Hervey-Jumper, MD, University of California San Francisco

Irina Balyasnikova, PhD, Northwestern University

Ali Shilatifard, PhD, Northwestern University

Ranjit Bindra, MD, PhD, Yale

Yon Son Betty Kim, MD, PhD, MD Anderson Cancer Center

Robert Prins, PhD, University of California Los Angeles

Shawn Hingtgen, PhD, University of North Carolina

Roland Friedel, PhD, Icahn School of Medicine at Mount Sinai

Balveen Kaur, PhD, Georgia Cancer Center at Augusta University

David Reardon, MD, Dana-Farber Cancer Institute and Harvard Medical School

Hong Chen, PhD, Washington University in St. Louis

Ananth V. Annapragada, PhD, Texas Children’s Hospital

Jose Javier Bravo-Cordero, PhD, Icahn School of Medicine at Mount Sinai

Robert G. Thorne, PhD, Denali Therapeutics and the University of Minnesota – Minneapolis

Kannan Rangaramanujam, PhD, MS, Johns Hopkins Medicine

Natalie Artzi, PhD, Wyss Institute and Harvard Medical School

Attend the Symposium

Find more information on what to expect at our symposium and how to register.


Please reach out to us with any questions or concerns.

Email us